Dai-ichi Karkaria Ltd
Incorporated in 1963, Dai-ichi Karkaria Ltd
is in the business of manufacture and sale
of Specialty chemicals[1]
- Market Cap ₹ 298 Cr.
- Current Price ₹ 401
- High / Low ₹ 799 / 233
- Stock P/E 37.8
- Book Value ₹ 253
- Dividend Yield 0.50 %
- ROCE 4.38 %
- ROE 4.28 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 19.3% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 18.2%
Cons
- The company has delivered a poor sales growth of 11.1% over past five years.
- Company has a low return on equity of 3.31% over last 3 years.
- Earnings include an other income of Rs.5.99 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
147 | 181 | 194 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 132 | 181 | |
134 | 159 | 161 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 167 | |
Operating Profit | 13 | 22 | 32 | 17 | 15 | -11 | -5 | -14 | -18 | 16 | 6 | 14 |
OPM % | 9% | 12% | 17% | 14% | 10% | -12% | -5% | -14% | -15% | 9% | 5% | 8% |
10 | 15 | 4 | 12 | 6 | 2 | -0 | 87 | 8 | 17 | 24 | 6 | |
Interest | 1 | 0 | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 |
Depreciation | 2 | 5 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 |
Profit before tax | 20 | 32 | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 18 | 8 |
Tax % | 24% | 28% | 35% | 24% | 27% | -48% | -0% | 13% | -0% | 16% | 27% | 27% |
16 | 23 | 22 | 25 | 14 | -13 | -23 | 51 | -18 | 20 | 14 | 9 | |
EPS in Rs | 20.94 | 31.24 | 29.34 | 33.43 | 18.32 | -16.92 | -30.76 | 68.02 | -24.20 | 26.94 | 18.65 | 12.11 |
Dividend Payout % | 12% | 10% | 10% | 9% | 14% | -15% | -8% | 4% | -0% | 15% | 11% | 29% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 11% |
3 Years: | 14% |
TTM: | 38% |
Compounded Profit Growth | |
---|---|
10 Years: | -6% |
5 Years: | 19% |
3 Years: | 33% |
TTM: | 416% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 16% |
3 Years: | 12% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | -3% |
3 Years: | 3% |
Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | 80 | 101 | 119 | 142 | 151 | 135 | 112 | 163 | 142 | 162 | 173 | 181 |
1 | 1 | 1 | 4 | 77 | 104 | 108 | 20 | 22 | 38 | 19 | 13 | |
31 | 38 | 31 | 25 | 41 | 35 | 42 | 48 | 43 | 39 | 23 | 31 | |
Total Liabilities | 119 | 147 | 159 | 179 | 276 | 281 | 270 | 239 | 214 | 247 | 222 | 232 |
17 | 16 | 17 | 20 | 94 | 164 | 153 | 105 | 105 | 139 | 132 | 126 | |
CWIP | 7 | 6 | 14 | 32 | 43 | 5 | 3 | 0 | 2 | 0 | 2 | 1 |
Investments | 31 | 42 | 40 | 64 | 41 | 24 | 23 | 27 | 21 | 23 | 21 | 24 |
65 | 83 | 88 | 62 | 98 | 88 | 92 | 107 | 86 | 85 | 67 | 82 | |
Total Assets | 119 | 147 | 159 | 179 | 276 | 281 | 270 | 239 | 214 | 247 | 222 | 232 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
4 | 5 | 11 | 3 | -8 | 6 | 1 | -22 | -3 | 23 | 10 | 16 | |
-3 | -0 | -8 | -7 | -57 | -21 | 1 | 130 | -4 | -33 | 16 | -4 | |
-3 | -3 | -6 | 2 | 66 | 16 | -6 | -97 | -2 | 13 | -25 | -10 | |
Net Cash Flow | -2 | 3 | -3 | -2 | 2 | 1 | -4 | 11 | -10 | 4 | 1 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 75 | 76 | 70 | 59 | 75 | 65 | 70 | 89 | 53 | 53 | 62 | 60 |
Inventory Days | 51 | 53 | 51 | 78 | 74 | 98 | 104 | 133 | 93 | 59 | 77 | 60 |
Days Payable | 76 | 94 | 82 | 68 | 83 | 128 | 146 | 210 | 122 | 87 | 74 | 75 |
Cash Conversion Cycle | 50 | 34 | 39 | 70 | 66 | 36 | 28 | 11 | 24 | 25 | 65 | 45 |
Working Capital Days | 45 | 43 | 52 | 67 | 79 | 47 | 42 | 103 | 66 | 46 | 70 | 62 |
ROCE % | 17% | 23% | 28% | 17% | 8% | -7% | -4% | -8% | -12% | 8% | 0% | 4% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16h - Newspaper publication for extract of audited standalone and consolidated financial results for the quarter and financial year ended 31.3.2025.
-
Results Presentation For The Period Ended March 31, 2025
1d - FY25 results presentation highlighting steady growth, production efficiency, and ethoxylation capacity expansion.
-
Appointment Of Secretarial Auditor
1d - Re-appointment of independent director, senior management and secretarial auditor appointments, new MOA and AOA adoption.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
1d - Board approved director re-appointment, senior management and auditor appointments, and new MOA/AOA adoption.
-
Announcement under Regulation 30 (LODR)-Change in Management
1d - Board approved director re-appointment, senior management and auditor appointments, new MOA and AOA adoption.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is ISO 9001 certified and
in the business of development and manufacture of high-performance
specialty chemicals for various
applications. It has technical
collaboration with the Dai-
ichi Kogyo Seiyaku Co.
Ltd, of Japan